HCN通道在神经病理性疼痛中的作用研究进展
Research Progress on the Role of HCN Channel in Neuropathic Pain
DOI: 10.12677/IJPN.2023.123004, PDF,   
作者: 陆永利, 杨红卫*：三峡大学国家中医药管理局中药药理科研三级实验室，湖北 宜昌；三峡大学基础医学院机能学系，湖北 宜昌；三峡大学脑重大疾病研究所，湖北 宜昌
关键词: 神经病理性疼痛；HCN通道；信号通路；超极化激活的电流；Neuropathic Pain (NP)； Hyperpolarization Activates Cyclic Nucleotide-Gated Channel； Signaling Pathway； Hyperpolarization-Activated Current (Ih)
摘要: 神经病理性疼痛(Neuropathic pain, NP)是一种常见且难治的慢性疼痛，由躯体感觉系统的损伤或疾病引起，其产生和维持可能与神经损伤后引起的外周和中枢敏化有关。NP严重影响患者的正常生活，且目前临床上缺乏治疗NP的有效方法。尽管NP发病的机制尚未完全阐明，但研究表明超极化激活的环核苷酸阳离子(Hyperpolarization activates cyclic nucleotide-gated, HCN)通道参与NP的病理生理过程；HCN通道可通过多巴胺D1受体、cAMP-PKA、α2受体、5-HT7受体、CaMKII/CREB、mTORC1等信号通路调节NP的敏感化。因此HCN通道有望成为靶向干预治疗NP的药物靶点。本文将重点阐述HCN通道在NP中的作用及其细胞分子机制，旨在为NP治疗药物的研发提供理论依据和新的策略。
Abstract: Neuropathic pain (NP) caused by damage or disease of the somatosensory system is a common and refractory chronic pain. The mechanisms involved in induction and maintenance of NP have been associated with peripheral and central sensitization after nerve injury. There is no effective clinical treatment for NP at present and NP seriously affects the normal life of patients. The mechanisms underlying NP have not been fully elucidated, but the studies suggest that hyperpolarization activates cyclic nucleotide-gated (HCN) channel is involved in the path physiological process of NP. HCN channel modulates the sensitization of NP through the D1 receptor, cAMP-PKA, α2 receptor, 5-HT7 receptor, CaMKII/CREB and mTORC1 signaling pathways. This review focuses on the molecular and cellular mechanisms of the effect of HCN channels on NP, which may provide theoretical basis and new strategies for HCN channels as potential drug targets for targeted intervention therapy of NP.
文章引用：陆永利, 杨红卫. HCN通道在神经病理性疼痛中的作用研究进展[J]. 国际神经精神科学杂志, 2023, 12(3): 33-41. https://doi.org/10.12677/IJPN.2023.123004

参考文献

[1] Resta, F., Micheli, L., Laurino, A., et al. (2018) Selective HCN1 Block as a Strategy to Control Oxaliplatin-Induced Neuropathy. Neuropharmacology, 131, 403-413. [Google Scholar] [CrossRef] [PubMed]
[2] Jiang, Y.Q., Sun, Q., Tu, H.Y., et al. (2008) Characteristics of HCN Channels and Their Participation in Neuropathic Pain. Neurochemical Research, 33, 1979-1989. [Google Scholar] [CrossRef] [PubMed]
[3] Alcantara Montero, A., Ibor Vidal, P.J., Alonso Verdugo, A., et al. (2019) Update in the Pharmacological Treatment of Neuropathic Pain. Se-mergen, 45, 535-545. [Google Scholar] [CrossRef] [PubMed]
[4] Murnion, B.P. (2018) Neuropathic Pain: Current Definition and Review of Drug Treatment. Australian Prescriber, 41, 60-63. [Google Scholar] [CrossRef] [PubMed]
[5] Alles, S.R.A. and Smith, P.A. (2021) Peripheral Voltage-Gated Cation Channels in Neuropathic Pain and Their Potential as Therapeutic Targets. Frontiers in Pain Research (Lausanne), 2, Article ID: 750583. [Google Scholar] [CrossRef] [PubMed]
[6] Lancon, K., Qu, C., Navratilova, E., et al. (2021) Decreased Do-paminergic Inhibition of Pyramidal Neurons in Anterior Cingulate Cortex Maintains Chronic Neuropathic Pain. Cell Re-ports, 37, Article ID: 109933. [Google Scholar] [CrossRef] [PubMed]
[7] Du, L., Wang, S.J., Cui, J., et al. (2013) Inhibition of HCN Channels within the Periaqueductal Gray Attenuates Neuropathic Pain in Rats. Behavioral Neuroscience, 127, 325-329. [Google Scholar] [CrossRef] [PubMed]
[8] Lee, M.C., Bond, S., Wheeler, D., et al. (2019) A Randomised, Dou-ble-Blind, Placebo-Controlled Crossover Trial of the Influence of the HCN Channel Blocker Ivabradine in a Healthy Volunteer Pain Model: An Enriched Population Trial. Pain, 160, 2554-2565. [Google Scholar] [CrossRef] [PubMed]
[9] Rivolta, I., Binda, A., Masi, A., et al. (2020) Cardiac and Neuronal HCN Channelopathies. Pflügers Archiv, 472, 931-951. [Google Scholar] [CrossRef] [PubMed]
[10] Santello, M. and Nevian, T. (2015) Dysfunction of Cortical Dendritic Integration in Neuropathic Pain Reversed by Serotoninergic Neuromodulation. Neuron, 86, 233-246. [Google Scholar] [CrossRef] [PubMed]
[11] Santoro, B. and Shah, M.M. (2020) Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels as Drug Targets for Neurological Disorders. Annual Review of Pharmacology and Toxicology, 60, 109-131. [Google Scholar] [CrossRef] [PubMed]
[12] Arakawa, K., Kaku, R., Kurita, M., et al. (2018) Prolonged-Duration Pulsed Radiofrequency Is Associated with Increased Neuronal Damage without Further Antiallo-dynic Effects in Neuropathic Pain Model Rats. Journal of Pain Research, 11, 2645-2651. [Google Scholar] [CrossRef] 
[13] Yang, L., Ding, W., You, Z., et al. (2019) Alleviation of Trigeminal Neuropathic Pain by Electroacupuncture: The Role of Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel Protein Expression in the Gasserian Ganglion. Acupuncture in Medicine, 37, 192-198. [Google Scholar] [CrossRef] [PubMed]
[14] Hsiao, H.T., Liu, Y.C., Liu, P.Y., et al. (2019) Concerted Sup-pression of Ih and Activation of IK(M) by Ivabradine, an HCN-Channel Inhibitor, in Pituitary Cells and Hippocampal Neurons. Brain Research Bulletin, 149, 11-20. [Google Scholar] [CrossRef] [PubMed]
[15] He, J.T., Li, X.Y., Zhao, X., et al. (2019) Hyperpolariza-tion-Activated and Cyclic Nucleotide-Gated Channel Proteins as Emerging New Targets in Neuropathic Pain. Reviews in the Neurosciences, 30, 639-649. [Google Scholar] [CrossRef] [PubMed]
[16] Jiang, Y.Q., Xing, G.G., Wang, S.L., et al. (2008) Axonal Ac-cumulation of Hyperpolarization-Activated Cyclic Nucleotide-Gated Cation Channels Contributes to Mechanical Allo-dynia after Peripheral Nerve Injury in Rat. Pain, 137, 495-506. [Google Scholar] [CrossRef] [PubMed]
[17] Emery, E.C., Young, G.T., Berrocoso, E.M., et al. (2011) HCN2 Ion Channels Play a Central Role in Inflammatory and Neuropathic Pain. Science, 333, 1462-1466. [Google Scholar] [CrossRef] [PubMed]
[18] Yang, Y., Xia, Z., Meng, Q., et al. (2018) Dexmedetomidine Relieves Neuropathic Pain by Inhibiting Hyperpolarization-Activated Cyclic Nucleotide-Gated Currents in Dorsal Root Ganglia Neurons. Neuroreport, 29, 1001-1006. [Google Scholar] [CrossRef] 
[19] Bernal, L. and Roza, C. (2018) Hyperpolarization-Activated Channels Shape Temporal Patterns of Ectopic Spontaneous Discharge in C-Nociceptors after Peripheral Nerve Injury. European Journal of Pain, 22, 1377-1387. [Google Scholar] [CrossRef] [PubMed]
[20] Tsantoulas, C., Mooney, E.R. and McNaughton, P.A. (2016) HCN2 Ion Channels: Basic Science Opens up Possibilities for Therapeutic Intervention in Neuropathic Pain. Biochemical Journal, 473, 2717-2736. [Google Scholar] [CrossRef] 
[21] Cordeiro Matos, S., Zhang, Z. and Seguela, P. (2015) Peripheral Neu-ropathy Induces HCN Channel Dysfunction in Pyramidal Neurons of the Medial Prefrontal Cortex. Journal of Neuro-science, 35, 13244-13256. [Google Scholar] [CrossRef] 
[22] Balducci, V., Credi, C., Sacconi, L., et al. (2021) The HCN Channel as a Pharmacological Target: Why, Where, and How to Block It. Progress in Biophysics and Molecular Biology, 166, 173-181. [Google Scholar] [CrossRef] [PubMed]
[23] Blom, S.M., Pfister, J.P., Santello, M., et al. (2014) Nerve Injury-Induced Neuropathic Pain Causes Disinhibition of the Anterior Cingulate Cortex. Journal of Neuroscience, 34, 5754-5764. [Google Scholar] [CrossRef] 
[24] Ma, Y., Chen, J., Yu, D., et al. (2021) cAMP-PKA Sig-naling Is Involved in Regulation of Spinal HCN Channels Function in Diabetic Neuropathic Pain. Neuroscience Letters, 750, Article ID: 135763. [Google Scholar] [CrossRef] [PubMed]
[25] Cordeiro Matos, S., Zamfir, M., Longo, G., et al. (2018) Nora-drenergic Fiber Sprouting and Altered Transduction in Neuropathic Prefrontal Cortex. Brain Structure and Function, 223, 1149-1164. [Google Scholar] [CrossRef] [PubMed]
[26] Wan, Y. (2008) Involvement of Hyperpolarization-Activated, Cy-clic Nucleotide-Gated Cation Channels in Dorsal Root Ganglion in Neuropathic Pain. Acta Physiologica Sinica, 60, 579-580.
[27] Santello, M., Bisco, A., Nevian, N.E., et al. (2017) The Brain-Penetrant 5-HT7 Receptor Agonist LP-211 Reduces the Sensory and Affective Components of Neuropathic Pain. Neurobiology of Disease, 106, 214-221. [Google Scholar] [CrossRef] [PubMed]
[28] Liu, X., Zhang, L., Jin, L., et al. (2018) HCN2 Contributes to Ox-aliplatin-Induced Neuropathic Pain through Activation of the CaMKII/CREB Cascade in Spinal Neurons. Molecular Pain, 14. [Google Scholar] [CrossRef] [PubMed]
[29] Ma, X., Du, W., Wang, W., et al. (2020) Persistent Rheb-Induced mTORC1 Activation in Spinal Cord Neurons Induces Hypersensitivity in Neuropathic Pain. Cell Death & Disease, 11, 747. [Google Scholar] [CrossRef] [PubMed]
[30] Gao, S.H., Wen, H.Z., Shen, L.L., et al. (2016) Activation of mGluR1 Contributes to Neuronal Hyperexcitability in the Rat Anterior Cingulate Cortex via Inhibition of HCN Chan-nels. Neuropharmacology, 105, 361-377. [Google Scholar] [CrossRef] [PubMed]
[31] Cook, D.C. and Goldstein, P.A. (2021) Non-Canonical Molecular Targets for Novel Analgesics: Intracellular Calcium and HCN Channels. Current Neuropharmacology, 19, 1937-1951. [Google Scholar] [CrossRef] 
[32] Bernard Healey, S.A., Scholtes, I., Abrahams, M., et al. (2021) Role of Hyperpolarization-Activated Cyclic Nucleotide-Gated Ion Channels in Neuropathic Pain: A Proof-of-Concept Study of Ivabradine in Patients with Chronic Peripheral Neuropathic Pain. Pain Reports, 6, e967. [Google Scholar] [CrossRef] 
[33] Tibbs, G.R., Rowley, T.J., Sanford, R.L., et al. (2013) HCN1 Channels as Targets for Anesthetic and Nonanesthetic Propofol Analogs in the Amelioration of Mechanical and Thermal Hyperalgesia in a Mouse Model of Neuropathic Pain. Journal of Pharmacology and Experimental Therapeutics, 345, 363-373. [Google Scholar] [CrossRef] [PubMed]
[34] Dini, L., Del Lungo, M., Resta, F., et al. (2018) Selec-tive Blockade of HCN1/HCN2 Channels as a Potential Pharmacological Strategy against Pain. Frontiers in Pharmacolo-gy, 9, Article No. 1252. [Google Scholar] [CrossRef] [PubMed]
[35] Dewar, M.B. (2019) HCN3 Has Minimal Involvement in the Sensa-tion of Acute, Inflammatory and Neuropathic Pain. The Journal of Physiology, 597, 5333-5334. [Google Scholar] [CrossRef] 
[36] Tae, H.S., Smith, K.M., Phillips, A.M., et al. (2017) Gabapentin Modulates HCN4 Channel Voltage-Dependence. Frontiers in Pharmacology, 8, Article No. 554. [Google Scholar] [CrossRef] [PubMed]